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caveolin-1 expression in hepatocytes
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Cédric Coulouarn3 and Steven Dooley1*
Abstract
Background: Dedifferentiation and loss of hepatocyte polarity during primary culture of hepatocytes are major
drawbacks for metabolic analyses. As a prominent profibrotic cytokine and potent inducer of epithelial
mesenchymal transition (EMT), TGF-β contributes to these processes in liver epithelial cells. Yet, a distinction
between culture dependent and TGF-β driven hepatocyte dedifferentiation has not been shown to date.
Results: Here, we show that in both settings, mesenchymal markers are induced. However, upregulation of Snai1
and downregulation of E-Cadherin are restricted to TGF-β effects, neglecting a full EMT of culture dependent
hepatocyte dedifferentiation. Mechanistically, the latter is mediated via FAK/Src/ERK/AKT pathways leading to the
induction of the oncogene caveolin-1 (Cav1). Cav1 was recently proposed as a new EMT marker, but our results
demonstrate Cav1 is not up-regulated in TGF-β mediated hepatocyte EMT, thus limiting validity of its use for this
purpose. Importantly, marking differences on Cav1 expression exist in HCC cell lines. Whereas well differentiated
HCC cell lines exhibit low and inducible Cav1 protein levels - by TGF-β in a FAK/Src dependent manner, poorly
differentiated cell lines display high Cav1 expression levels which are not further modulated by TGF-β.
Conclusions: This study draws a detailed distinction between intrinsic and TGF-β mediated hepatocyte
dedifferentiation and elucidates cellular pathways involved. Additionally, by evaluating the regulation of the
oncogene Cav1, we provide evidence to argue against Cav1 as a reliable EMT marker.
Background
Primary cultures of human or rodent hepatocytes are of
particular value for investigating drug metabolism and
toxicity. However, basic functional hepatocyte features
such as bile canaliculi formation, bile secretion, polarity
and metabolic activities (including detoxification by Cyp
and other drug-metabolizing enzymes) are rapidly lost
during culture on a collagen layer (monolayer or 2D cul-
ture). To overcome these limitations, alternative hepato-
cyte culture systems have been developed, including
co-culture systems, bioreactors and 3D systems, where
hepatocytes are embedded in a soft collagen matrix
[1,2].
However, hepatocyte culture on a single stiff collagen
surface possesses interesting features for researchers. In-
deed, monolayer culture of primary hepatocytes offers
an astonishing view on cell plasticity, and allows delinea-
tion of pathways regulating hepatocyte polarity and
homeostasis [3]. Even though hepatocyte dedifferenti-
ation in culture has not been deeply investigated with re-
spect to epithelial to mesenchymal transition (EMT) so
far, the switch of cell morphology toward a fibroblastoid
phenotype and the induction of EMT-associated colla-
gen I expression argues for such process in vitro [4].
Transforming growth factor beta (TGF-β), a pleio-
tropic cytokine, is considered as the most potent profi-
brotic mediator in diverse organ diseases [5]. It is also
recognized as a strong EMT inducer in various epithelial
cell types including hepatocytes cultured on a stiff colla-
gen matrix [3,6,7]. These observations raise the question
whether TGF-β acts as an accelerator of the intrinsic de-
differentiation process or whether culture and TGF-β
mediated EMT are distinct processes.
Caveolin-1 is the forming protein of caveolae, invagi-
nations of the plasma membrane, and defines a particu-
lar endocytic route [8]. Although caveolin-1 expression
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is elevated in hepatocellular carcinoma (HCC), its func-
tion as a tumor suppressor or promoter is still debated
[9-12]. Recently, caveolin-1 was shown as being required
for mitochondrial function and lack of caveolin-1
resulted in apoptotic susceptibility [13]. Thus, an in-
crease of caveolin-1 might serve for enhanced mitochon-
drial stability under stressful conditions like liver fibrosis
and inflammation as well as for an additional survival
strategy for cancer cells.
TGF-β was shown to enhance tumor growth under cer-
tain conditions and has recently been demonstrated to in-
crease caveolin-1 expression in the pluripotent human
embryonic carcinoma cell line NT2/D1 as well as in murine
mammary epithelial cells (NMuMG) [14].
In this study, we define pathways responsible for
caveolin-1 expression in dedifferentiating hepatocytes
and discern important differences of intrinsic and TGF-
β induced hepatocyte dedifferentiation. Whereas TGF-β
driven hepatocyte EMT is not accompanied by increased
caveolin-1 levels, intrinsic dedifferentiation is mediated
via FAK/Src and the downstream pathways ERK1/2 and
AKT, causing a tremendous increase of caveolin-1 ex-
pression. Further, the latter process is completely inde-
pendent of the Snai1 transcription factor, a major EMT
mediator. Finally, in contrast to primary hepatocytes,
TGF-β is capable of inducing caveolin-1 expression in
well differentiated, but not in dedifferentiated HCC cell
lines.
Results
Culture induced hepatocyte dedifferentiation leads to
upregulation of mesenchymal markers and caveolin-1
Hepatocytes cultured on collagen monolayer rapidly de-
differentiate. This was nicely illustrated by staining of
F-actin fibres utilizing phalloidin. At day 1, primary
hepatocytes still exhibited a polar organization with
actin fibers forming a belt on the inner side of the cell
membrane (Figure 1A). Starting at day 2, hepatocytes
spread on the substratum and re-structure the actin
cytoskeleton. TGF-β treatment enhanced cytoskeleton
remodelling in hepatocytes which finally culminated in
fibroblastoid morphology with limited cell-cell contacts
(resembling EMT). In contrast, although culture induced
dedifferentiation affected the actin structures, cell-cell
contacts were still visible (Figure 1A).
Besides the loss of polar shape during culture, mesen-
chymal markers were expressed, as illustrated by the in-
duction of N-Cadherin and Vimentin within four days of
culture. Furthermore, this process correlated with the
activation of MAPK/ERK and AKT signaling pathways
(Figure 1B). A striking increase in Collagen 1α1 mRNA
expression level was observed after 4 days of culture
(p < 0.001), thus further supporting the gain of mesen-
chymal properties of cultured hepatocytes (Figure 1C).
Besides expression of these markers, caveolin-1 was
strongly induced both at mRNA (p < 0.001 at day 3
and 4) and protein levels (Figure 1B, D). Intriguingly,
protein levels of the epithelial marker E-Cadherin were
not decreased during intrinsic dedifferentiation. Never-
theless, localization of E-Cadherin was affected as dur-
ing dedifferentiation immunostaining demonstrated a
reduced localization at cell-cell contacts/tight junc-
tions (data not shown & [3]).
The FAK/Src signaling pathway mediates caveolin-1
expression
We have shown previously that the integrin/FAK/Src axis
triggered hepatocyte dedifferentiation [3]. Thus, we next
investigated whether this pathway also contributed to
caveolin-1 induction. Inhibition of FAK was achieved using
the small chemical inhibitor PF573228 which led to abroga-
tion of FAK tyrosine 397 and to a reduction of Src tyrosine
527 phosphorylation. The blockage of FAK subsequently
attenuated caveolin-1 upregulation (Figure 2A). Addition-
ally, downstream signaling of FAK, in terms of pSrc, pAKT
and pERK was affected (Figure 2B). To further elucidate
that Src family members are essential in mediating activa-
tion of AKT and ERK, two Src inhibitors were applied and
downstream signaling was evaluated. Inhibition of Src with
SU6656 and PP2 (Figure 2B) yielded in reduced activity of
ERK and AKT pathways. Application of different inhibitors
of Src family members is adequate in our experimental set-
ting due to their variant substrate specificity [15] and thus
distinct downstream effects.
Similarly, as observed with the FAK inhibitor, Src block-
age significantly prevented upregulation of caveolin-1 in
hepatocytes on protein (Figure 3A, B) and mRNA levels
(Figure 3C, D). Attenuated hepatocyte dedifferentiation was
demonstrated by reduced expression of N-Cadherin and
Collagen 1α1 mRNA, as well as sustained E-Cadherin ex-
pression when cells were cultured in presence of Src family
inhibitors (Figure 3A, B, E, F).
AKT and ERK contribute to caveolin-1 upregulation
Due to a recent report about the relevance of MAPK/
ERK and AKT signaling pathways in modulating hepato-
cyte plasticity in monolayer culture, and the observation
of affected ERK and AKT phosphorylation upon FAK/
Src inhibition (Figure 2B and [3]), we intended to define
the relevance of these pathways on caveolin-1 expres-
sion. Blocking culture dependent AKT activation with
Ly294002 inhibitor sig nificantly reduced caveolin-1 pro-
tein and mRNA levels (Figure 4A, B). As also Collagen
1α1 induction was significantly blunted (Figure 4C), in-
hibition of AKT affected hepatocyte dedifferentiation
and caveolin-1 induction. Next, U0126 was applied to
interfere with ERK1/2 activity during hepatocyte culture
on collagen monolayer. This led to reduced caveolin-1
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and Collagen 1α1 expression, similar to the result
obtained upon AKT pathway blunting (Figure 4D-F). In
summary, both ERK1/2 and AKT pathways influenced
hepatocyte dedifferentiation (vimentin, Figure 4A, D)
and caveolin-1 expression.
Snai1 is not involved in hepatocyte dedifferentiation and
caveolin-1 induction
Considering the unique role of Snail transcription
factor family in driving EMT, we tested whether
Snai1 and Slug (Snai2) were involved in the culture
dependent dedifferentiation process of hepatocytes.
Intriguingly, during culture, Snai1 mRNA levels only
slightly increased. As a potent mediator of EMT,
TGF-β was previously shown to induce Snai1
expression. Accordingly, TGF-β treatment tremen-
dously increased Snai1 expression in a time
dependent manner (Figure 5A). Additionally, we
evaluated a potential role of Slug during intrinsic de-
differentiation. We found Slug expression levels un-
changed during 4 days of culture (Figure 5B) and
thus rule out a potential function in the process of
dedifferentiation. However, TGF-β1 induced a late
and in comparison to Snai1, moderate Slug induc-
tion at day 3 and 4 of treatment (up to 16-fold after
4 day treatment). Therefore, Slug is not an early
EMT mediator of TGF-β in hepatocytes.
To further confirm that Snai1 is not involved in the regula-
tion of caveolin-1 expression, we showed that hepatocytes
isolated from hepatocyte specific Snai1 knockout mice
Figure 1 Intrinsic hepatocyte dedifferentiation is accompanied with upregulation of mesenchymal markers. (A) Time course of cultured
hepatocytes stained with phalloidin. Starting on day 2, hepatocytes loose polar structure. Lower panel shows cells treated with TGF-β1 leading to
similar actin remodeling and reduced cell-cell contacts over time. (B) Western blot showing a time course of murine hepatocytes cultured in
monolayer on a stiff collagen matrix. Mesenchymal markers are induced and AKT and ERK signaling pathways are activated over time. Caveolin-1
is strongly upregulated during culture. (C) Collagen 1α1 (p < 0.001 at d3 and d4) and (D) caveolin-1 mRNA (p < 0.001 at d3 and d4) are
upregulated in culture over time.
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underwent culture dependent dedifferentiation and up-
regulated caveolin-1 expression comparable to controls
(Figure 5C). The increase of pERK during dedifferentiation is
also not affected by Snai1 expression, indicating indepen-
dency of a Snai1 mediated mechanism. To prove the
conditional Snai1 knockout, mRNA levels of Snai1 under
basal conditions and after 6 h TGF-β treatment were investi-
gated. Basal expression of Snai1 was weak in controls, and
strongly reduced in hepatocytes from Snai1 ko mice. Upon
TGF-β treatment, Snai1 expression boosted within 6 h in
Figure 2 FAK activation influences caveolin-1 induction. (A) FAK and Src phosphorylation increases over time in culture. Blocking FAK
phosphorylation with PF573228 (4 μM) culminates in reduced phospho-Src and N-Cadherin expression as well as attenuated caveolin-1
upregulation. E-Cadherin expression is unchanged. Caveolin-1 expression was densitometrically analyzed. A significant downregulation was
observed at day 3 (p = 0.002) and day 4 (p = 0.011) (B) Blocking FAK (PF573228, 4 μM) leads to reduced AKT and ERK phosphorylation. Inhibition
of Src kinases results in attenuated AKT and ERK phosphorylation. SU6656 (15 μM) additionally affects FAK phosphorylation, whereas PP2 (10 μM)
does not. These data indicate that FAK signals via Src/ERK/AKT.
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wild types up to 35 fold whereas Snai1 ko hepatocytes did
not induce significant expression (Figure 5D). These observa-
tions suggested that culture induced hepatocyte dedifferenti-
ation does not resemble a classical EMT due to Snai1
independency.
TGF-β attenuates culture mediated caveolin-1
upregulation
As the above findings enabled a clear discrimination
between culture induced dedifferentiation and TGF-β
mediated EMT, it was of interest to determine whether
Figure 3 Src is a critical mediator for caveolin-1 induction. (A) SU6656 (SU; 15 μM) was used to block Src activity. Blockage yielded in
reduced caveolin-1 protein (evaluated with densitometry) similar to (B) where PP2 (10 μM) was used. (C, D) Caveolin-1 mRNA expression is also
reduced during culture in presence of inhibitors (p = 0.002 for SU6656 at d4; p < 0.001 for PP2 at d4). (E, F) Induction of Collagen 1α1 was
reduced upon Src inhibition with both inhibitors (SU6656: p < 0.001; PP2: p = 0.005).
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TGF-β was able to induce caveolin-1 expression in pri-
mary hepatocytes. To test this hypothesis, monolayer
cultured hepatocytes were treated with TGF-β for several
days and subsequently caveolin-1 expression was ana-
lyzed. Caveolin-1 protein levels ascended over time in
the controls, but to a lesser extent in cells treated with
TGF-β (Figure 6A). This was paralleled by a weaker in-
crease of caveolin-1 mRNA expression upon TGF-β
stimulation during culture (Figure 6B). To determine
whether the attenuation of caveolin-1 induction by
TGF-β was Smad or non-Smad pathway dependent,
Smad4 was knocked down to abrogate the canonical
Smad pathway. TGF-β stimulation in Smad4 knock
down hepatocytes did not lead to a reduction in
caveolin-1 protein levels, as compared to controls
(Figure 6C). Furthermore, Smad4 knockdown yielded in
Smad3 hyperactivation, likely due to reduced nuclear
shuttling with subsequent attenuated dephosphorylation
and degradation of phospho-Smads. Noteworthy, Src
phosphorylation was triggered by TGF-β stimulation,
and this was not altered by knock down of Smad4.
As the relevance of Src in inducing caveolin-1 was evident,
Src phosphorylation was blocked by SU6656 and cells were
subsequently treated with TGF-β.As shown in Figure 6D,
TGF-β reduced caveolin-1 expression in controls. SU6656
also affected caveolin-1 expression compared to untreated
controls. When TGF-β and SU6656 were combined, no
additive effect on expression was detectable. These findings
argue for a dominant role of the Smad pathway on caveolin-
1 repression, capable of overruling the Src axis. We therefore
conclude that TGF-β is not able to induce caveolin-1 in nor-
mal epithelial hepatocytes.
TGF-β induces caveolin-1 in low caveolin-1 expressing
HCC cell lines
Caveolin-1 has been linked to cancer, including HCC. Several
studies correlated caveolin-1 expression and prognosis of the
patient. Except one study, increased caveolin-1 levels have
Figure 4 The AKT and ERK pathways are required for caveolin-1 induction. (A) Blocking AKT activation with Ly294002 decreased caveolin-1
upregulation on protein and (B) mRNA level (p = 0.018). (C) Induction of Collagen 1α1 mRNA, a mesenchymal marker, was completely abolished
when AKT signaling was blocked (P < 0.001). (D) Inhibition of ERK activation via the small molecule inhibitor U0126 (U5: 5 μM; U10: 10 μM)
culminated in strongly reduced caveolin-1 induction on protein and (E) mRNA level (p < 0.001). (F) ERK affects upregulation of Collagen 1α1 (p <
0.001) for mRNA expression studies, U0126 was used at a conc. of 10 μM.
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been linked to poor prognosis [9-12]. Six HCC cell lines,
namely Hep3B, HUH-7, PLC/PRF/5, FLC-4, HLE and HLF,
were screened for caveolin-1 expression and we found marked
differences on both mRNA and protein level (Figure 7A).
Previously, Hep3B, HUH-7 and PLC/PRF/5 were classified as
differentiated and HLE and HLF as dedifferentiated HCC cell
lines [16]. Noteworthy, FLC-4 cell line has an epithelial pheno-
type and was reported to demonstrate hepatocyte like
functions [17]. However, these cells exhibit elevated basal mi-
gration capacity (Figure 7B) and have undergone the E- to N-
Cadherin switch (not shown). Based on these observations,
FLC-4 were assigned as “dedifferentiated” together with HLE
and HLF cells. Considering the tumor promoting function of
TGF-β in HCC, the cell lines were analyzed for TGF-β regula-
tion of caveolin-1 expression. Interestingly, low expressing cell
lines (Hep3B, HUH-7 and PLC/PRF/5) respond to TGF-β
Figure 5 The Snai1 family is not involved in intrinsic dedifferentiation and caveolin-1 upregulation. (A) Snai1 is slightly upregulated
during dedifferentiation and tremendously and time dependently induced by TGF-β1 stimulation (**p < 0.005 at all time points when comparing
untreated with TGF-β1; p < 0.05 untreated d3 vs. untreated d1). (B) No change of Snai2 (Slug) expression could be detected in hepatocytes
cultured for 4 days. Beginning on day 3, TGF-β did increase its expression (p ≤ 0.002 at d3 and d4 comparing expression of untreated vs. TGF-β1).
(C) Dedifferentiating hepatocytes from wild type and Snai1 ko mice were analyzed for dedifferentiation events with Western blot. No alterations
in ERK activation and caveolin-1 induction were observed. (D) Proof of hepatocyte specific Snai1 knockout. Basal Snai1 expression was very weak
in wild type hepatocytes (based on qPCR data) and almost absent in Snai1 ko hepatocytes. Induction of Snai1 expression was triggered by
TGF-β1 stimulation for 6 h. Control hepatocytes responded with strong induction, whereas Snai1 knockout hepatocytes did not induce
expression (p < 0.001).
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stimulation with significant upregulation of caveolin-1 expres-
sion (Figure 8A) on mRNA level. Similar results were obtained
on protein level, although the kinetics of upregulation differed
(Figure 8B-D). As the low expressing cell lines show a more
differentiated phenotype, as compared to the high expressing
ones, it can be hypothesized that TGF-β mediated cancer
EMT is accompanied with an increase of caveolin-1 expres-
sion. Due to the implications of the FAK/Src axis on caveolin-
1 expression [14], Hep3B were treated with PP2 or PF573228
to inhibit Src and FAK phosphorylation and subsequently sti-
mulated with TGF-β1 for 24 h. Blocking of Src/FAK affected
caveolin-1 induction (Figure 8D). To conclude, low caveolin-1
expressing HCC cell lines induce its expression upon TGF-β
challenge via a FAK/Src-dependent pathway.
Discussion
Hepatocyte dedifferentiation in collagen monolayer cul-
ture is a major obstacle for toxicity screening. During
culture, hepatocyte metabolic functions are altered due
to downregulation of metabolic enzymes including the
broad family of Cyp enzymes [18,19]. Polarity establish-
ment and maintenance are critical processes to regulate
hepatocyte function and therefore in focus of research.
Hepatocyte dedifferentiation impressively documents the
cellular plasticity and evidences that the differentiation
status in vivo does not have to be terminal. A recent in-
triguing finding underlining hepatocyte plasticity has
been reported by Sahin and co-workers, who described
differentiation of hepatocytes into liver progenitor cells
[20]. Others made observations of EMT during hepato-
cellular cancer progression. Interestingly, primary hepa-
tocytes have also been shown to undergo EMT upon
TGF-β stimulation in vitro [7]. In contrast, in vivo EMT
of hepatocytes during liver damage and fibrogenesis has
recently been declined, although this was mainly related
to transdifferentiation into myofibroblasts [21] and does
not exclude phenotypical changes of hepatocytes into
other directions.
In vitro, a distinction between intrinsic hepatocyte de-
differentiation and TGF-β mediated EMT has not yet
been drawn. A recent study describes the capability of
TGF-β to induce caveolin-1 expression in NMuMG and
NT2/D1 cells lines, which has been linked to FAK/Src
signaling [14]. Additionally, in a hepatocyte cell line
(E14 MMH), TGF-β mediated EMT was shown to re-
quire FAK signaling [22]. Furthermore, intrinsic hepato-
cyte dedifferentiation in culture has also been connected
to FAK/Src signaling [3]. Indeed, our study defines that
Figure 6 Effects of TGF-β1 on caveolin-1 induction. (A) TGF-β1 treated hepatocytes display attenuated caveolin-1 protein upregulation. TGF-
β1 dependent EMT induction is reflected by E-Cadherin downregulation. (B) Similar to the protein regulation, mRNA levels of caveolin-1 are less
induced compared to corresponding controls (p≤ 0.001 after 2, 3 and 4 days). (C) Knockdown of Smad4 attenuates TGF-β1 mediated caveolin-1
repression. (D) Inhibition of Src using SU6656 (15 μM) blocked intrinsic and TGF-β mediated upregulation of N-Cadherin and caveolin-1.
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FAK/Src activity is the driving force of hepatocyte dedif-
ferentiation and caveolin-1 upregulation and thus, the
FAK signaling pathway is implicated in TGF-β triggered
effects. During intrinsic hepatocyte dedifferentiation, the
downstream signaling routes MEK/ERK and PI3K/AKT
are activated and subsequently regulate the induction of
caveolin-1. Noteworthy, the dedifferentiation process in
monolayer culture primes hepatocytes for proliferation
as shown recently by microarray analysis and therefore
may reflect a phenotype contributing to liver regener-
ation [23]. Due to linkage of caveolin-1 to proliferation
in many settings and cell types [24], it might as well
function in modulating hepatocyte proliferation. In sharp
contrast, the EMT inducing TGF-β/Smad signaling
pathway is overruling the above FAK/Src mediated
signals and does not increase caveolin-1 levels in hepato-
cytes. In this context, the EMT promoting transcription
factor Snai1 is induced weakly during culture and is
strongly upregulated upon TGF-β treatment. This find-
ing is consistent with the observation that the epithelial
marker E-Cadherin is not downregulated on protein
level during culture, although mesenchymal markers are
induced. However, E-Cadherin localization at the plasma
membrane is affected and therewith tight junction for-
mation is compromised, leading to reduced cell-cell ad-
hesion (but less compared to TGF-β mediated effects), a
feature of mesenchymal cell types. TGF-β challenge, how-
ever, led to reduced E-Cadherin expression, which is
mediated by Snai1 repression of the gene. For further delin-
eation, upregulation of caveolin-1 and induction of
Figure 7 HCC cell lines and caveolin-1 expression. (A) HUH-7, Hep3B and PLC/PRF/5 are weak caveolin-1 expressing cells (both on mRNA and
protein level, qPCR data normalized to 18S rRNA), whereas the dedifferentiated lines HLE, HLF and FLC-4 demonstrate high expression levels. (B)
Based on elevated basal migration capacity, assessed with the transwell assay, HLE, HLF and FLC-4 are considered dedifferentiated (see text for
details).
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mesenchymal markers are discrete from Snai1 function.
Additionally, induction of mesenchymal markers and
caveolin-1 are likely non-related events, as TGF-β is inducing
the mesenchymal phenotype without increasing caveolin-1
expression. Further studies will shed light on the different
mechanisms regulating different steps of the hepatocyte dif-
ferentiation programmes.
Recognizing FAK/Src signaling as an important driver
of caveolin-1 expression in hepatocytes, it is worth specu-
lating about their microenvironment during disease devel-
opment. During fibrogenesis and cancer development, the
liver’s microarchitecture changes, comprising upregulation
of extracellular matrix deposition, increased liver stiffness
and a shift to fibril forming collagens (mainly type I and
III). Integrins are sensors of the extracellular milieu and
subsequently signal status information into the cell, com-
monly involving FAK/Src. Thus, the extracellular matrix
composition of the liver may be of relevance for changes
in caveolin-1 expression and subsequent modulation of
hepatocyte function also in vivo.
Hepatocellular cancer commonly develops after decades of
liver fibrosis/cirrhosis, where extensive matrix remodelling
has taken place. Therefore, the increase of caveolin-1 in pro-
gressed HCC likely results from matrix signals (but other
regulatory factors, e.g. cholesterol, have been described
[25,26]). However, we also found that TGF-β is capable to in-
crease caveolin-1 expression in some HCC cells lines. A
common feature of this observation was the relatively low
basal expression of caveolin-1 as in contrast, the dedifferen-
tiated, high caveolin-1 expressing cell lines did not increase
expression upon TGF-β stimulation. This points to an inter-
esting aspect. TGF-β is considered as a tumor suppressor;
however, frequently and especially in progressed disease
stages, its function may switch to a tumor promoter [27]. In
our study, we define caveolin-1 as a non-target of TGF-β in
untransformed hepatocytes, whereas in early transformed
(differentiated HCC) cancer cell lines, TGF-β is mediating
enhanced expression of caveolin-1 and therewith may pro-
mote tumor proliferation and migration/invasion, functions
that have been attributed to caveolin-1. With regard to EMT,
in hepatocytes, caveolin-1 cannot be considered as an indica-
tor (or marker) of EMT processes as it does not occur as a
TGF-β target gene during this process. However the role in
cancer EMT has yet to be defined.
Figure 8 TGF-β induces caveolin-1 expression in a subset of HCC cell lines. (A) qReal-time analysis of TGF-β1 treated HCC cell lines. The low
caveolin-1 expressing lines respond to TGF-β via an upregulation of expression (*p < 0.05; **p < 0.01), whereas HLE, HLF and FLC-4 do not change
expression upon TGF-β1 challenge. (B) Western blot of PLC/PRF/5 lysates revealed caveolin-1 upregulation after 12 and 24 h of TGF-β1 treatment.
(C) HUH-7 cells require 36 h TGF-β1 treatment to enhance caveolin-1 protein expression. (D) Hep3B cells strongly elevate caveolin-1 expression
after 24 h of TGF-β1 treatment. Blocking FAK or Src phosphorylation by applying the chemical inhibitors PF573228 (4 μM) or SU6656 (15 μM)
abolished the induction of caveolin-1 protein expression upon TGF-β1 stimulation.
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Conclusion
Morphological similar processes of intrinsic and TGF-β
induced hepatocyte dedifferentiation underlie distinct
molecular mechanisms including activation of signalling
pathways and induction of target genes. Snai1 is a medi-
ator of TGF-β triggered EMT, whereas it is not involved
in intrinsic differentiation. Furthermore, caveolin-1, sug-
gested as an EMT marker, is repressed by TGF-β and
strongly induced during hepatocyte culture. In contrast,
caveolin-1 turns into a TGF-β target in transformed
hepatocytes (HCC cell lines), where Smad and non-
Smad/FAK/Src signalling pathways contribute. These
findings imply that a further delineation of programmes
leading to hepatocyte plasticity, depending on culture
conditions, is inevitable.
Additionally, the TGF-β dependent transcriptional pat-
terns are strongly depending on the differentiation status
of the hepatocyte. Further research on primary hepato-
cytes and cell lines will generate insights into the inte-
gration of Smad and non-Smad pathways leading to a
unique cell response, especially in context of TGF-β’s
functional switch from a tumor suppressor towards a
tumor promoter in cancerogenesis.
Materials and methods
Cell culture
Primary hepatocytes were isolated from livers of male
C57BL/6 wild type mice by collagenase perfusion. Hepa-
tocytes then were plated on collagen coated plates and
cultured in Williams E medium supplemented with Pen/
Strep, L-glutamine, dexamethasone and FCS [6]. After
attachment (4 h), cells were cultured in medium lacking
FCS. For analyzing the function of Snai1 during intrinsic
dedifferentiation, hepatocytes were isolated from B6;129-
TgN(Alb-Cre-/+)Snai1tm1MhM mice with a hepatocyte
specific deletion of functional Snai1 gene [28]. From
these animals and corresponding wild type mice, hepato-
cytes were isolated as described above. HCC cell lines
used in this study: HUH-7, Hep3B, PLC/PRF/5, HLE,
HLF, and FLC-4. For stimulation experiments, FCS free
medium containing inhibitors and/or TGF-β was
refreshed every 24 h.
Reagents and antibodies
Recombinant TGF-β1 was purchased from Peprotech
(Hamburg, Germany) and used at a final concentration
of 5 ng/ml. Antibodies used: pAKT, pSrc527 (Cell Sig-
naling), pSmad3 (epitomics), caveolin-1, GAPDH, pERK,
pFAK397 and horseradish peroxidase-linked anti mouse
and rabbit secondary antibodies were from SantaCruz.
E-Cadherin (BD Biosystems), β-actin (Sigma-Aldrich),
N-Cadherin, tubulin and vimentin were obtained from
abcam. Inhibitors used in this study: PF573228 (Sigma-
Aldrich), SU6656 (Calbiochem), PP2, LY294002, U0126
(Tocris).
Immunofluorescence of F-actin
F-actin fibres were visualized using Alexa Fluor 488
phalloidin (invitrogen) and nuclei using Draq5 (alexis
biochemicals). Cells were cultured on collagen coated
glass slides and fixed with 2% PFA, permeabilized with
0.3% Triton-X 100 in PBS followed by a final 4% PFA
fixation step. Fixed cells were incubated with phalloidin
and Draq5 in a 1% BSA/PBS solution for 1 h. After
washing with PBS, cells were mounted on object slides
and images acquired using the confocal microscope
Leica TCS SP2.
Western blot analysis
Hepatocyte lysates were taken with RIPA buffer (50
mMTris-HCl (pH 7.5), 150 mMNaCl, 1% Nonidet P-
40 (NP40), 0.5% sodium deoxycholate, 0.1% SDS,
Proteases Inhibitor Cocktail, Phosphatase Inhibitor
Cocktail II (Roche, Germany)). Protein concentration
was determined using the DC protein assay (Bio-
Rad). 30 μg protein per sample were separated by
SDS-PAGE and blotting was processed as described
[29]. Then, membranes were developed using ECL
solution and the Chemi-Smart (Vilber Lourmat)
system.
RNA isolation, reverse transcription and qRT-PCR
Total RNA was extracted using the RNAeasy Mini
Kit (Qiagen). Subsequently, cDNA was synthesized
from 1 μg RNA with the Quantitect Reverse Tran-
scription kit (Qiagen). qRT-PCR was performed
using taqman technology on a Stratagene Mx3005P.
Snai1, Snai2, PPIA, caveolin-1 and Collagen 1α1 pri-
mer mixes were purchased from Applied Biosystems.
For normalization of cell line data, 18S rRNA spe-
cific taqman primers were used.
RNA interference
Transfection with siRNA was essentially performed as in
[29]. In brief, RNAiMAX (invitrogen) was used as trans-
fection reagent. A final concentration of 10 nM was
chosen. Oligos were pools obtained from Dharmacon.
Transfection was carried out 4 h after seeding of primary
hepatocytes and transfection mix was incubated o/n.
Stimulation experiments were conducted 36 h post
transfection.
Migration assay
For elucidating migration capacity of the different
HCC cell lines, a transwell assay was applied. Trans-
well inserts (BD) were used (pore size 8 μm). 25,000
starved cells per insert were seeded. The upper
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compartment contained 1% BSA, whereas the lower
part contained 10% FCS to induce migration. Cells
were allowed to migrate for 13 h. Subsequently, cells
from both compartments were trypsinized and an
ATP assay (CellTiter-Glo, Promega) was conducted
to evaluate % of migrated cells (values lower com-
partment divided by sum of both compartments).
Densitometry
For quantitative analysis of Western blots, Aida
Image Analyzer v. 4.25 was used. Each value was
calculated from three independent experiments. Ex-
pression was normalized to GAPDH protein levels.
Normalized control was set to 1 at each time point
(day3 and day4).
Statistics
Significance was calculated with the two-tailed Student’s
t-test. Values were pooled from at least three independ-
ent experiments or as indicated.
Abbreviations
EMT: Epithelial mesenchymal transition; HCC: Hepatocellular carcinoma;
TGF-β: Transforming growth factor beta.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CM designed, performed and analyzed experiments, wrote the manuscript,
JD performed experiments with HCC cell lines; YL performed experiments
and analysed data, wrote manuscript. FS did experiments with primary
hepatocytes and analysed RNA and protein samples; SM designed
experiments and helped drafting the manuscript, AM isolated primary
hepatocytes and helped to draft manuscript, CC helped to draft the
manuscript, SD supervised the experiments, analysed data and wrote the
manuscript. All authors read and approved the final manuscript.
Acknowledgement
This work was funded by the BMBF programme “Virtual liver” and the
Deutsche Forschungsgemeinschaft DO 373/8-1 and TRR-SFB 77.
Author details
1Department of Medicine II, Section Molecular Hepatology, Medical Faculty
Mannheim, Heidelberg University, Mannheim, Germany. 2Department of
Molecular Cell Biology and Centre for Biomedical Genetics, Leiden University
Medical Center, 2300 RC, Leiden, The Netherlands. 3INSERM, UMR991,
University of Rennes 1, Pontchaillou University Hospital, 2 rue Henri Le
GuillouxRennes F-35033, France.
Received: 7 September 2012 Accepted: 21 December 2012
Published: 22 January 2013
References
1. Guillouzo A, Guguen-Guillouzo C: Evolving concepts in liver tissue
modeling and implications for in vitro toxicology. Expert Opin Drug Metab
Toxicol 2008, 4:1279–1294.
2. Kim Y, Rajagopalan P: 3D hepatic cultures simultaneously maintain
primary hepatocyte and liver sinusoidal endothelial cell phenotypes.
PLoS One 2011, 5:e15456.
3. Godoy P, Hengstler JG, Ilkavets I, Meyer C, Bachmann A, Muller A, Tuschl G,
Mueller SO, Dooley S: Extracellular matrix modulates sensitivity of
hepatocytes to fibroblastoid dedifferentiation and transforming growth
factor beta-induced apoptosis. Hepatology 2009, 49:2031–2043.
4. Baker TK, Carfagna MA, Gao H, Dow ER, Li Q, Searfoss GH, Ryan TP:
Temporal gene expression analysis of monolayer cultured rat
hepatocytes. Chem Res Toxicol 2001, 14:1218–1231.
5. Pohlers D, Brenmoehl J, Loffler I, Muller CK, Leipner C, Schultze-Mosgau S,
Stallmach A, Kinne RW, Wolf G: TGF-beta and fibrosis in different organs -
molecular pathway imprints. Biochim Biophys Acta 2009, 1792:746–756.
6. Weng HL, Ciuclan L, Liu Y, Hamzavi J, Godoy P, Gaitantzi H, Kanzler S,
Heuchel R, Ueberham U, Gebhardt R, et al: Profibrogenic transforming
growth factor-beta/activin receptor-like kinase 5 signaling via connective
tissue growth factor expression in hepatocytes. Hepatology 2007,
46:1257–1270.
7. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, Kalluri R:
Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to
mesenchymal transition. J Biol Chem 2007, 282:23337–23347.
8. Parton RG, Simons K: The multiple faces of caveolae. Nat Rev Mol Cell Biol
2007, 8:185–194.
9. Cokakli M, Erdal E, Nart D, Yilmaz F, Sagol O, Kilic M, Karademir S, Atabey N:
Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation
with differentiation state, motility and invasion. BMC Cancer 2009, 9:65.
10. Tang Y, Zeng X, He F, Liao Y, Qian N, Toi M: Caveolin-1 is related to
invasion, survival, and poor prognosis in hepatocellular cancer. Med
Oncol 2012, 29(2):977–984.
11. Yang SF, Yang JY, Huang CH, Wang SN, Lu CP, Tsai CJ, Chai CY, Yeh YT:
Increased caveolin-1 expression associated with prolonged overall
survival rate in hepatocellular carcinoma. Pathology 2010, 42:438–445.
12. Zhang ZB, Cai L, Zheng SG, Xiong Y, Dong JH: Overexpression of caveolin-
1 in hepatocellular carcinoma with metastasis and worse prognosis:
correlation with vascular endothelial growth factor, microvessel density
and unpaired artery. Pathol Oncol Res 2009, 15:495–502.
13. Bosch M, Mari M, Herms A, Fernandez A, Fajardo A, Kassan A, Giralt A, Colell
A, Balgoma D, Barbero E, et al: Caveolin-1 deficiency causes cholesterol-
dependent mitochondrial dysfunction and apoptotic susceptibility. Curr
Biol 2011, 21:681–686.
14. Bailey KM, Liu J: Caveolin-1 up-regulation during epithelial to
mesenchymal transition is mediated by focal adhesion kinase. J Biol
Chem 2008, 283:13714–13724.
15. Chen T, George JA, Taylor CC: Src tyrosine kinase as a chemotherapeutic
target: is there a clinical case? Anticancer Drugs 2006, 17:123–131.
16. Coulouarn C, Factor VM, Thorgeirsson SS: Transforming growth factor-beta
gene expression signature in mouse hepatocytes predicts clinical
outcome in human cancer. Hepatology 2008, 47:2059–2067.
17. Laurent T, Murase D, Tsukioka S, Matsuura T, Nagamori S, Oda H: A novel
human hepatoma cell line, FLC-4, exhibits highly enhanced liver
differentiation functions through the three-dimensional cell shape. J Cell
Physiol 2012, 227:2898–2906.
18. Kidambi S, Yarmush RS, Novik E, Chao P, Yarmush ML, Nahmias Y: Oxygen-
mediated enhancement of primary hepatocyte metabolism, functional
polarization, gene expression, and drug clearance. Proc Natl Acad Sci USA
2009, 106:15714–15719.
19. Yarmush ML, Toner M, Dunn JC, Rotem A, Hubel A, Tompkins RG: Hepatic
tissue engineering. Development of critical technologies. Ann N Y Acad
Sci 1992, 665:238–252.
20. Chen Y, Wong PP, Sjeklocha L, Steer CJ, Sahin MB: Mature hepatocytes
exhibit unexpected plasticity by direct dedifferentiation into liver
progenitor cells in culture. Hepatology 2012, 55(2):563–574.
21. Taura K, Miura K, Iwaisako K, Osterreicher CH, Kodama Y, Penz-Osterreicher
M, Brenner DA: Hepatocytes do not undergo epithelial-mesenchymal
transition in liver fibrosis in mice. Hepatology 2010, 51:1027–1036.
22. Cicchini C, Laudadio I, Citarella F, Corazzari M, Steindler C, Conigliaro A,
Fantoni A, Amicone L, Tripodi M: TGFbeta-induced EMT requires focal
adhesion kinase (FAK) signaling. Exp Cell Res 2008, 314:143–152.
23. Zellmer S, Schmidt-Heck W, Godoy P, Weng H, Meyer C, Lehmann T, Sparna
T, Schormann W, Hammad S, Kreutz C, et al: Transcription factors ETF, E2F,
and SP-1 are involved in cytokine-independent proliferation of murine
hepatocytes. Hepatology 2010, 52:2127–2136.
24. Boscher C, Nabi IR: Caveolin-1: role in cell signaling. Adv Exp Med Biol 2012,
729:29–50.
25. Bist A, Fielding PE, Fielding CJ: Two sterol regulatory element-like
sequences mediate up-regulation of caveolin gene transcription in
response to low density lipoprotein free cholesterol. Proc Natl Acad Sci
USA 1997, 94:10693–10698.
Meyer et al. Cell Communication and Signaling 2013, 11:6 Page 12 of 13
http://www.biosignaling.com/content/11/1/6
26. Dasari A, Bartholomew JN, Volonte D, Galbiati F: Oxidative stress induces
premature senescence by stimulating caveolin-1 gene transcription
through p38 mitogen-activated protein kinase/Sp1-mediated activation
of two GC-rich promoter elements. Cancer Res 2006, 66:10805–10814.
27. Dooley S, Weng H, Mertens PR: Hypotheses on the role of transforming
growth factor-beta in the onset and progression of hepatocellular
carcinoma. Dig Dis 2009, 27:93–101.
28. Murray SA, Carver EA, Gridley T: Generation of a Snail1 (Snai1) conditional
null allele. Genesis 2006, 44:7–11.
29. Meyer C, Godoy P, Bachmann A, Liu Y, Barzan D, Ilkavets I, Maier P, Herskind
C, Hengstler JG, Dooley S: Distinct role of endocytosis for Smad and non-
Smad TGF-beta signaling regulation in hepatocytes. J Hepatol 2011,
55:369–378.
doi:10.1186/1478-811X-11-6
Cite this article as: Meyer et al.: Distinct dedifferentiation processes
affect caveolin-1 expression in hepatocytes. Cell Communication and
Signaling 2013 11:6.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Meyer et al. Cell Communication and Signaling 2013, 11:6 Page 13 of 13
http://www.biosignaling.com/content/11/1/6
